Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news



EFSA calls for characterisation work as probiotic resubmissions loom

1 commentBy Shane Starling , 10-Nov-2011
Last updated on 14-Nov-2011 at 02:37 GMT2011-11-14T02:37:28Z

EFSA calls for characterisation work as probiotic resubmissions loom

EFSA has approached an expert who has already worked with its health claims panel to make a report on the characterisation of probiotic strains – an issue that led to the rejection of 260 out of 300 probiotic health claim dossiers - and most of which are being resubmitted.

EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA) unit head, Dr Juliane Kleiner, said the expert had been approached due to their “extensive experience”.

“The contracting authority [EFSA] has discretion to select the specific tenderer who is invited to participate in such low value negotiated procedures,” Dr Kleiner said.

“This selection is based on the candidate’s experience and technical expertise in the field as well as on the legal requirement that the contractor shall not have any conflict of interest. The expert who has been invited to participate in the negotiated procedure has extensive experience in the area of characterisation of microorganisms and evaluation of health claims and has performed previous work for the NDA Panel related to the characterisation of microorganisms.”

“Therefore and in the light of ensuring consistency, this expert has been approached by EFSA to submit an offer.”

“One of us should take that opportunity”

Members of the probiotic academic community had mixed reactions to the need for such a report. Stephan Bischoff, PhD, professor and chair at the Department of Nutritional Medicine at the University of Hohenheim, welcomed it.

“I think it is a very positive signal that EFSA looks here for external advice,” he said.

“One of us should take that opportunity,” he said referring to the European pool of probiotic academics. “Preferentially someone familiar with the microbiological field.”

Ger Rijkers, PhD, from the University Medical Center in Utrecht, in the Netherlands, wondered about the need for the report. I assume that most of the microorganisms are already sufficiently characterised – at least, that is what the NDA panel stated in their evaluations – but they have published once or twice a list of strains which were not fully characterised.”


The report tender comes as those 300 probiotic rejections are likely to be reassessed by the NDA after characterisation and other scientific issues gained a sympathetic hearing with the European Commission.

“EFSA launched a negotiated procedure for preparatory work in relation to the characterisation of certain microorganisms in the context of the reassessment of certain Article 13 health claims,” EFSA press chief, Steve Pagani said.

1 comment (Comments are now closed)

probiotics claims

Probiotics are essential to improve digestion, to aid continueing absorbtion of drugs and nutrition. Probiotics are necessary to maintain individual needs.

Report abuse

Posted by harry
16 November 2011 | 09h482011-11-16T09:48:11Z

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars